Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Dapatkan Wang Tunai sebanyak 10$ untuk setiap Rakan Pro+ yang anda Rujuk!

Carlisle Companies Incorporated

Carlisle Companies Incorporated

CSL · NYSE
CSL · NYSE
361.96
USD14.904.29%
Carlisle Companies Incorporated
CSL
361.96
USD14.904.29%

Gambaran keseluruhan

Profil

Perangkaan

Pendapatan

Kewangan

Pemegang

Trend

Perdagangan Orang Dalam

Pemfailan

Berita

Gambaran keseluruhanProfilPerangkaanPendapatanKewanganPemegangTrendPerdagangan Orang DalamPemfailanBerita

Tarikh

Pemacu

Tajuk

Sumber

    Carlyle Secured Lending wins shareholders' approval for CSL III merger

    SeekingAlpha

      Carlisle Companies to acquire ThermaFoam

      SeekingAlpha

        Australia's CSL tests 'dynamic pricing' of donor blood amid cost surge https://t.co/CykGCAS08t https://t.co/7jUKI1Hiai

        Reuters
        @Reuters

          #earnings after the close https://t.co/lObOE0dgsr $AMZN $INTC $SNAP $NET $FSLR $PINS $X $TMUS $GILD $AMGN $DXCM $SKX $COF $MDLZ $PFG $AYX $SAM $LHX $DLR $SWN $BJRI $AEM $SGEN $ACCD $FICO $IMAX $WY $RMD $ALSN $VRSN $KNSL $CINF $CAMP $CUBE $MHK $CC $CSL $APPF $SKYW $SLCA $HIG $SM… https://t.co/fgu6udfLVA

          eWhispers
          @eWhispers

            ASX LIVE: UBS says buy Lynas Corp; Citi lifts CSL valuation, CBA sinks - The Australian Financial Review

            Australian Financial Review

              ASX to rise on Wall Street rally; Ansell, CSL, Hardie to report - The Australian Financial Review

              Australian Financial Review

                Australia's CSL prices hemophilia gene therapy at $3.5 million https://t.co/QGzVIar2t1 https://t.co/IxqONuFHjg

                Reuters
                @Reuters

                  Australia's CSL prices hemophilia gene therapy at $3.5 million https://t.co/dN2tFuTR20 https://t.co/uMJ7w0nwRX

                  Reuters
                  @Reuters

                    Australia's CSL raises annual profit forecast on Swiss acquisition https://t.co/wqlpHo8dnB https://t.co/rKev6ZNCTi

                    ReutersBiz
                    @ReutersBiz

                      Australia's CSL raises annual profit forecast on Swiss acquisition https://t.co/DlH9KaGNLO https://t.co/BLvBaiGON6

                      Reuters
                      @Reuters

                        Australia's CSL raises annual profit forecast on Swiss acquisition https://t.co/zdHh9jN9PK https://t.co/uViSfLGvD0

                        ReutersBiz
                        @ReutersBiz

                          CSL reports tender offer results of Vifor Pharma acquisition

                          SeekingAlpha

                            ASX adds 1.1pc: Liontown, Vicinity, CSL soar - The Australian Financial Review

                            Australian Financial Review

                              Fund managers ready for blockbuster CSL raising - The Australian Financial Review

                              Australian Financial Review

                                Australia's CSL to buy Swiss drugmaker Vifor for $11.7 bln https://t.co/yAXehoR5P6 https://t.co/2Xw8qHaTOO

                                Reuters
                                @Reuters

                                  Australia's CSL to buy Swiss drugmaker Vifor for $11.7 bln https://t.co/TAmlOyjUup https://t.co/L1bqjH0MS1

                                  Reuters
                                  @Reuters

                                    Australia's CSL to buy Swiss drugmaker Vifor for $11.7 billion https://t.co/QQRowy1JeB https://t.co/MwLHome0QL

                                    Reuters
                                    @Reuters

                                      Vifor Pharma shares jump 15% as takeover talks with CSL confirmed https://t.co/6wo1OQsoSZ https://t.co/4hYCRrVhGW

                                      Reuters
                                      @Reuters

                                        Australia's CSL confirms buyout interest in Swiss drugmaker Vifor https://t.co/855vQHoycl https://t.co/VtMuX9MR9s

                                        Reuters
                                        @Reuters

                                          Australia's CSL confirms talks to buy Swiss drugmaker Vifor https://t.co/1iudlH69e7 https://t.co/Ty6SaZCrsj

                                          Reuters
                                          @Reuters

                                            Australia's CSL in exclusive talks for $7 bln buyout of Swiss Vifor Pharma - report https://t.co/ygwDZMGk2b https://t.co/sRPjZTAmC5

                                            Reuters
                                            @Reuters

                                              Australia's CSL in exclusive talks to buy Swiss Vifor Pharma - report https://t.co/8Zqn2kL8d4 https://t.co/CJVRnmTavH

                                              Reuters
                                              @Reuters

                                                Bigger-than-usual #earnings moves today from $CLF $SNAP $INTC $AXP $STX $WRB $USX $SMPL $GNTX $FFIN $SIVB $CSL https://t.co/1pgojKC5HH https://t.co/ol1XiMeBYW

                                                eWhispers
                                                @eWhispers

                                                  #earnings after the close today https://t.co/lObOE0uRjZ $SNAP $INTC $CMG $SAM $OLN $MAT $WHR $CE $BJRI $SIVB $CSL $VLRS $BOOM $PINE $RHI $WRB $VICR $OZK $USX $ASB $PBCT $CSTR $WAL $GBCI $WSFS $TRST $PSTV $FFBC $MYFW $BCBP $SGLB $KB $SRCE https://t.co/M0SDYeUQmO

                                                  eWhispers
                                                  @eWhispers

                                                    Australia's CSL reaffirms commitment to making AstraZeneca COVID vaccine https://t.co/yWFpU3o1yX https://t.co/qnh7kOiUha

                                                    Reuters
                                                    @Reuters

                                                      Profit season: CBA, CSL and BHP strengthen their domination of index - The Australian Financial Review

                                                      Australian Financial Review

                                                      Soalan Lazim

                                                      Berapa harga saham Carlisle Companiesorporated hari ini?

                                                      Apakah simbol saham Carlisle Companiesorporated?

                                                      Adakah harga saham CSL sedang naik?

                                                      Apakah cadangan penganalisis untuk CSL?

                                                      Apakah nilai pasaran CSL?

                                                      Adakah CSL mengeluarkan laporan kewangan?

                                                      Bila tarikh laporan pendapatan seterusnya CSL?

                                                      Berapa pendapatan CSL untuk suku tahunan lepas?

                                                      Berapa hasil CSL untuk suku tahunan lepas?

                                                      Berapa Pendapatan Bersih CSL untuk suku tahunan lepas?

                                                      Adakah CSL membayar dividen?

                                                      Berapa ramai pekerja yang ada di CSL?

                                                      Apakah EBITDA CSL?

                                                      Bagaimana untuk membeli saham CSL?

                                                      Patutkah saya melabur dalam saham CSL?